THE problem of systemic arterial embolism in rheumatic heart disease does not end after the patient has survived the acute episode. As protection from re-embolism, which threatens in some 45 per cent ...
Credit: Patrick J. Lynch, medical illustrator; C. Carl Jaffe, MD, cardiologist. Adjunctive left atrial appendage (LAA) ligation failed to increase the efficacy of catheter pulmonary vein isolation ...
Please provide your email address to receive an email when new articles are posted on . Outcomes for ablation of persistent AF by pulmonary vein antral isolation (PVAI) alone have been historically ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--SentreHEART, Inc., the manufacturer of the LARIAT Suture Delivery Device, today announced that it has received approval for an Investigational Device Exemption ...
Please provide your email address to receive an email when new articles are posted on . After successful percutaneous left atrial appendage ligation with the Lariat device, incomplete closure of the ...
A new device designed to close the left atrial appendage (LAA) and prevent strokes in patients with atrial fibrillation (A-fib) demonstrates a high rate of successful closure with minimal access ...
The Nature Index 2024 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
Surgically ligating the left atrial appendage (LAA) during implantation of the HeartMate 3 left ventricular assist device (LVAD; Abbott) does not affect survival or hemocompatibility-related adverse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results